Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-05-27
Original SEC Filing: Click here

---

Webplus: BSPM/20090527/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 Investments in Infrastructure Expected To Positively Effect Performance This Year New York, New York – May 27, 2009 – Biostar Pharmaceuticals, Inc. (“Biostar” or the “Company”) (OTCBB: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664

---

---

Webplus: BSPM/20090527/8-K/1/000.htm SEC Original: biostar-8k5272009.htm
FORM 8-K CURRENT REPORT May 27, 2009 Date of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland (State or other jurisdiction of incorporation) 333-147363 (Commission 20-5101287 (IRS Employer Identification No.) No. 588 Shiji Avenue, Xiangyang City, Shaanxi Province , 712046 (Zip Code) 86- 029-3368 6 638 Benjamin Tan, Esq. Sichenzia Ross Friedman Ference LLP 61 Broadway, 32 Floor

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-05-27CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046